Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradation
Roland Meisel(Düsseldorf University Hospital), Dagmar Dilloo(Düsseldorf University Hospital)
Cited by 1,628
Related Papers
Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus+ Hodgkin's Disease
|The Journal of Experimental Medicine|2004|390